You are about to exit the Consilient Health website to visit an independent third party website which is not under the control of Consilient Health. Consilient Health makes no warranties or representations of any kind as to the accuracy, completeness, reliability or usefulness of any information contained in third party sites and shall have no liability for any loss or damage of any kind that may arise from your use of such content or information.
Inclusion of any third party link does not imply an endorsement or recommendation by Consilient Health Ltd.
Please click ok if you wish to continue to the third party website or click cancel if you wish to return to altavita.ie.
CITIDARON® is indicated for smoking cessation and reduction of nicotine cravings in smokers who are willing to stop smoking. The treatment goal of CITIDARON® is the permanent cessation of the nicotine containing products use.
Healthcare professionals are asked to report any suspected adverse reactions. To report an adverse event or a product complaint about a Consilient Health medicine, please contact Consilient Health at [email protected] or 012057766. Adverse events and product complaints may also be reported to the Health Products Regulatory Authority. Reporting form and information can be found at http://www.hpra.ie then click on “report an issue”.
IE-CH-1438(2) Date of Preparation April 2024
(function(t,e,s,n){var o,a,c;t.SMCX=t.SMCX||[],e.getElementById(n)||(o=e.getElementsByTagName(s),a=o[o.length-1],c=e.createElement(s),c.type="text/javascript",c.async=!0,c.id=n,c.src="https://widget.surveymonkey.com/collect/website/js/tRaiETqnLgj758hTBazgdws7k5QmnfCdd2cjjySZdrIUgzqN1wKhsoc33uvarp3E.js",a.parentNode.insertBefore(c,a))})(window,document,"script","smcx-sdk"); Create your own user feedback survey